Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials (Q30767882)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

E Perucca

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

B E Gidal

2

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Eugène Baltès

3

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Epilepsy Research

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

47-56

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of drug interactions in epilepsy therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology and therapeutic use of the new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of dose increments on serum carbamazepine concentration in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of levetiracetam

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900250-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0920-1211(02)00250-4

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30767882&oldid=1647824399"